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Background: Clinical auditing is an emerging instrument for quality assessment and improvement.
Moreover, clinical registries facilitate medical research as they provide ‘real world’ data. It is important
that entered data are robust and reliable. The aim of this study was to describe the evolving procedure
and results of data verification within the Dutch Institute for Clinical Auditing (DICA).
Methods: Data verification performed on several (disease-specific) clinical registries between 2013 and
2015 was evaluated. Sign-up, sample size and process of verification were described. For each procedure,
hospitals were visited by external data managers to verify registered data. Outcomes of data verification
were completeness and accuracy. An assessment of the quality of data was given per registry, for each
participating hospital. Using descriptive statistics, analyses were performed for different sections within
the individual registries.
Results: Seven of the 21 registries were verified, involving 174 visits to hospital departments. A
step-by-step description of the data verification process was provided. Completeness of data in the
registries varied from 97⋅2 to 99⋅4 per cent. Accuracy of data ranged from 88⋅2 to 100 per cent. Most
discrepancies were observed for postoperative complications (0⋅7–7⋅5 per cent) and ASA classification
(8⋅5–11⋅4 per cent). Data quality was assessed as ‘sufficient’ for 145 of the 174 hospital departments (83⋅3
per cent).
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Introduction
Clinical auditing is predominantly an instrument for qual-
ity assessment and improvement in healthcare that can
help to improve patient outcomes1–4. Moreover, clini-
cal registries facilitate evidence-based medical research as
they provide ‘real world’ data of patients. In 2009, the
nationwide Dutch ColoRectal Audit (DCRA) was initi-
ated by the Association of Surgeons of the Netherlands5.
Together with the establishment of other clinical reg-
istries, this led to the foundation of the Dutch Institute
for Clinical Auditing (DICA) in 20114–7. Today, 21 clin-
ical registries are facilitated by DICA, and by 2016 more
than 500 000 patients had already been registered8. The
clinical registries are disease-specific, and 16 of the 21
registries are surgical registries. In the Netherlands, all
hospitals have an obligation to participate in these reg-
istries. Annually, a set of hospital-specific outcomes are
published on a public website, although only after approval
by the board of each hospital9. These outcomes are used
by policy-makers, health insurance companies and patient
federations to assess hospital performance.
A prerequisite for using these data for comparison of
quality between hospitals is that the entered data are robust
and reliable. The validity of entered data is essential,
because they are used for medical and epidemiological out-
come research. A recent validation study by Cundall-Curry
and colleagues10 emphasized the need for data uploaded
to a national registry to be checked. Another validation
of data quality in a national registry has been described
by Linder et al.11, who showed that the database of the
registry contained reliable data. A systematic approach for
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data verification in nationwide clinical registries has not
been described. This study aimed to describe the procedure
of data verification used by DICA, as well as the results of
each procedure of data verification and the lessons learned
from each procedure.
Methods
This was a retrospective descriptive study of data ver-
ification in nationwide registries in the Netherlands, a
high-income country in western Europe with approxi-
mately 17 million inhabitants. Healthcare insurance is
obligatory. Most secondary healthcare is provided in public
hospitals. Secondary healthcare was provided in 71 hospi-
tals in 2018. Since 2009, several nationwide registries have
been set up by what is now known as DICA. In this study,
data verifications performed between 2013 and 2015 were
eligible.
Data entry in the registries
Medical professionals have been responsible for the correct
registration of their data in the registries. At the start of
the DCRA, the majority of surgeons recorded the data
themselves. Today, the recording of data is performed
by medical specialists, trainees, physician assistants, data
managers, research and administrative nurses. The medical
specialist remains the final manager responsible for the
quality of the data entered. Data are either uploaded in
a web-based system or delivered by the hospitals as a
batch, at least once a year but preferably more often to
facilitate quality improvements. Hospitals adhere to annual
deadlines to deliver all data.
Organizational structure of registries in DICA
Each registry is led by a clinical audit board, consisting
of medical professionals mandated by their professional
association. The registries also have a scientific commit-
tee, comprising representatives of the participating centres.
Together with the scientific bureau of DICA, this scien-
tific committee defines valid quality indicators, coordinates
outcomes research, and is responsible for the quality of
the data.
Procedures to maintain the quality of registered
data
In each clinical registry, the reliability of data is improved
and verified in four ways. Verification systems are inte-
grated in the web-based survey, so that the registrar
receives direct feedback on erroneous, missing or unlikely
data items while entering the data.
DICA uses a signalling list that reports erroneous and
missing data for all patients in a hospital. Clinical experts
receive a weekly updated report with their outcomes for use
in clinical auditing. This report also provides the number
of registered patients and the completeness of the data,
which can help to identify errors early. Finally, external data
verification can contribute in determining the reliability of
the data.
External data verification
A first pilot project on external data verification was ini-
tiated by the Association of Surgeons of the Netherlands
in 2014. This led to the formation of a data verifica-
tion department at DICA that coordinates the procedures
of external verification. An independent data verification
committee was assigned, which consists of medical experts,
a biostatistician, a deputy of theDutchHealth Care Inspec-
torate and a deputy from the Netherlands Patients Fed-
eration. Since the first procedure in 2014, the procedure
of external data verification has been optimized based on
experience gained during previous procedures.
External data verification is done by a third trusted party
to guarantee the privacy of patients: Medical Research
Data Management (MRDM), Deventer, the Nether-
lands. MRDM is NEN 7510:2011 and ISO 27001:2013
certified, and complies with privacy regulations in the
Netherlands12.
Pilot verification project
In the pilot project, the longest existing registries of DICA,
the DCRA and the Dutch Upper Gastrointestinal Can-
cer Audit, were verified. In these verifications, 18 and 20
variables respectively were verified for all hospitals that par-
ticipated in the registry. Per hospital, data for 20 patients
were verified. With the experiences from the pilot project,
the data verification procedure has been modified and was
continued for other registries.
Regular data verifications
Patient and variable selection for verification
The scientific committee sets selection criteria for the types
of patient that should be included in the data verification,
and selects the variables to be verified.
Sign-up
Data verification was performed for each registry individ-
ually. All hospitals participating in the registry received an
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Table 1 Factors leading to the label ‘insufficient quality’
Factor Description
Completeness Of all patients who met the inclusion criteria, more than 2 per cent (at least 2 patients) were not registered
Mortality Of all patients who met the inclusion criteria, one or more patients died but were not registered at all or were not registered as ‘death’
Complication Of all patients who had a complication, the complication was not registered in more than 5 per cent (at least 3 patients)
Reintervention Of all patients who had a reintervention, the reintervention was not registered in more than 5 per cent (at least 3 patients)
Readmission Of all patients who had a readmission, the readmission was not registered in more than 5 per cent (at least 3 patients)
e-mail invitation to participate. In the invitation letter the
procedure, practical requirements and privacy of data ver-
ification were explained. Participation in data verification
was voluntary and free of costs for the hospitals, although
results were reported to the National Health Care Institute
(Zorginstituut Nederland), which is responsible for public
transparency of hospital-specific quality information in the
Netherlands.
Sample sizes
As previous studies were lacking, sample sizes were set
arbitrarily in a consensus meeting with the data verification
committee, which included a biostatistician. The preferred
number of hospitals to verify for each registry was set at
15. The number of patients to verify in each hospital was
based on a percentage of the annual hospital volume or a
set number of patients, with a minimum of 30 patients.
The process
The process of data verification in hospitals was done man-
ually by trained employees. They were all trained by DICA
in both the verification procedure and the medical content.
For each hospital, the completeness of the registration was
evaluated, and the accuracy of data assessed.
Completeness of the registry
For the verification, the data set of a complete registration
year was used. This data set was used for clinical audit-
ing, to calculate the quality indicators for each hospital.
To verify the completeness of the registry, hospitals were
asked to provide a patient list derived from their admin-
istrative system. A sample of the list was compared with
patients registered in the registry. Patients who were on the
patient list but missing from the registry were registered as
‘absent’.
Different types of patient list were used. In the first ver-
ified registries, a patient list derived from the nationwide
network and registry of histopathology and cytopathol-
ogy in the Netherlands (PALGA network13) or a patient
list with specific diagnosis–treatment combination (DBC)
codes, as recorded by the hospital administration and
Table 2 Characteristics and results of pilot verifications in 2013
DCRA pilot DUCA pilot
Registry year of veriﬁcation 2013 2013
Validation
Variables verified 20 18
Hospitals that signed up† 77 (88) 28 (88)
Hospitals verified 77 28
Patients verified per hospital 20 20
Completeness
Missing patients† 271 of 9679 (2⋅8) 10 of 1251 (0⋅8)
Missed deaths 24 1




Total no. of patients in
sample
1570 560
Discrepant deaths 5 (0⋅3) 0 (0)
Discrepant complications 117 (7⋅5) 17 (3⋅0)
Discrepant reinterventions 29 (1⋅8) 9 (1⋅6)
Discrepant ASA score 134 (8⋅5) 64 (11⋅4)
Discrepant radicality 4 of 415 (1⋅0) 11 of 235 (4⋅7)
Objections
No. of hospitals 22 16
Values in parentheses are percentages. *Sign-up for the Dutch ColoRec-
tal Audit (DCRA) and the Dutch Upper Gastrointestinal Cancer Audit
(DUCA) was done together. †Verification of completeness for DCRA and
DUCA was done for all registered patients.
insurance companies, was used. These DBC codes are used
in the Netherlands for reimbursement of all costs of deliv-
ered care and are comparable with ICD codes.
Not all methods mentioned above proved to be applica-
ble for every hospital because the PALGA system was not
used in all hospitals and in some cases the DBC codes could
differ between hospitals. Therefore it was decided that, for
the studied verifications, hospitals could choose the type
of patient list that fitted the aim of data verification and
matched their system.
Accuracy of the data
To assess the accuracy of the data, the original data derived
from the electronic patient records were comparedwith the
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Registry year of veriﬁcation 2014 2015 2015 2015 2015
Validation
Variables verified 17 6 9 9 13
Hospitals that signed up 29 of 43 (67) 36 of 53 (68) 39 of 60 (65) 12 of 20 (60) 12 of 19 (63)
Hospitals verified 15 13 14 12 12
Completeness
Patients verified per hospital ±26 ±22 ±21 ±35 ±30
Missing patients* 5 of 830 (0⋅6) 2 of 286 (0⋅7) 5 of 294 (1⋅7) 5 of 417 (1⋅2) 2 of 333 (0⋅6)
Missed deaths 0 0 0 0 0
Missed patients with severe complications 3 1 2 1 1
Accuracy
Total no. of patients in sample 388 281 298 420 358
Discrepant deaths 0 (0) 2 (0⋅7) 0 (0) 0 (0) 0
Discrepant complications 13 (4⋅6) 22 (7⋅4)
Discrepant severe complications 216 of 6596 (3⋅3)† 3 (0⋅7) 18 (5⋅0)
Discrepant reinterventions 0 (0) 0 (0) 3 (0⋅7)
Discrepant readmissions 6 (2⋅0)
Objections
No. of hospitals 6 7
Values in parentheses are percentages. Some cells are empty because the information was not available. *Verification of completeness for these registries was
done for all patients in the sample. †Percentage calculated as the proportion of discrepant registrations of the total complications that could be registered
for patients in the sample.
data in the registry. For the hospitals, it was not possible to
revise these data before data verification.
To register the accuracy of data, a web-based survey
was used in which the selected items to be verified were
prefilled, based on the registered data. Each variable was
assessed as ‘not discrepant’ or ‘discrepant’; missing data
were assessed as ‘discrepant’. When discrepancies were
observed, the correct information from the source data and
an additional explanation of discrepancy had to be noted.
As a minimum, the variables needed to calculate two of
the quality indicators were verified in all registries, includ-
ing ‘the percentage of patients with severe complications’
and ‘the percentage of patients who died within 30 days
after surgery’. For ‘severe complications’, different defini-
tions were used among registries.Mostly, the definitionwas
‘complications leading to a prolonged hospital stay, a rein-
tervention or death’. Another reason to verify a variable was
the use of a variable in the case-mix correction of outcome
indicators, the ASA score, which is a scale of the preopera-
tive fitness of patients5.
Analysis of the data verification and results
In the process of analysing the data, an assessment of the
observed discrepancies was done by an independent data
manager and a medical researcher from DICA. Data for
different hospitals were analysed separately. Completeness
and accuracy of the data were assessed with descriptive
statistics for different sections within the registries. Analy-
ses were performed using IBM SPSS® version 23.0 (IBM,
Armonk, New York, USA).
After evaluation of the discrepancies for each hospital by
the data manager and medical researcher, the results of this
evaluation were reported to the hospitals. In an adversarial
process, it was possible for each hospital to give a response
to the detected discrepancies. The independent verification
committee had the final say.
A composite measure was defined for the conclusion of
‘sufficient quality’ or ‘insufficient quality’. Table 1 shows
the criteria for the conclusion of ‘insufficient quality’ for
one of the procedures. For some other procedures, small
adjustments in thresholds were made due to a low number
of patients or events.
The conclusion regarding the quality of the data and
an anonymous summary report were communicated
to the hospitals, to help them learn from the discrep-
ancies and optimize their registration procedure. The
results were also reported to the National Health Care
Institute.
© 2019 The Authors. www.bjsopen.com BJS Open 2019; 3: 857–864
BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd
Data verification of clinical registries 861



























Lessons derived for the procedure of data veriﬁcation
More extensive training for verification employees needed x
Patient list not suitable x x x x x
Selection of hospitals: too many hospitals verified x x
Selection of variables: too many variables verified x x
Time-consuming to evaluate completeness for all patients rather than a sample x
Selection of patients: too few patients verified x x x
Privacy of patient records during the procedure was complex x x
Criteria for ‘sufficient/insufficient’ need to be set before start of data verification x x
Criteria for ‘sufficient/insufficient’ need to be changed x x x
Criteria for ‘sufficient/insufficient’ are without nuance x x x x x
Data verification has to become a continuous process in the audit cycle x x x x x x x
Lessons derived for registrars
Need to fill in all variables, also when not required x
Complications need to be registered more precisely x x x x x
ASA score needs to be registered as described in the anaesthesia report x x
Date of surgery has to be registered more precisely x x
Date of discharge has to be registered more precisely x
Hospitals must adhere to inclusion and exclusion criteria x
Lessons derived for the audits x
Need for clear definitions of variables x x x x x x
Error in data structure discovered x
Results
Since 2014, seven of the 21 registries have been verified
individually. Information about the different verifications
is shown in Tables 2 and 3.
Pilot verification project
In the pilot procedure, for all hospitals that signed up
(77 in DCRA and 28 in DUCA) 18–20 variables and all
patients eligible in 2013 were verified. This procedure was
found to be very time-consuming, logistically challenging
and financially unfavourable. Therefore, for subsequent
verifications a more limited set of variables was used. To
limit the number of hospitals, 15 hospitals per registry was
set; these hospitals were selected randomly by the third
trusted party, MRDM.
Regular verification project
Patient and variable selection for verification
The verified variables that were chosen differed between
registries; all verified variables are shown in Tables 2 and 3.
Sign-up
In the included seven data verification procedures, the
percentage of hospitals signed up for verification varied
between registries from 60 to 88 per cent.
In two verifications, some hospitals withdrew their
sign-up after selection because they were not able to
comply with the conditions for verification (no time and
priority for preparation). In two other verifications, fewer
than 15 hospitals signed up. In 2015, an online survey was
undertaken to investigate the reasons for refraining from
signing up. The commonest reasons included that centres
would have signed up but had forgotten, were too late or
miscommunicated (8 of 21 answers), lack of time (4 of 21),
and disagreed or did not comply with the legality of the
procedure of verification (4 of 21).
Sample size
The number of patient records that were verified varied per
registry, from 281 to 1570 (median 388).
Completeness of the registry
The percentage of unregistered patients varied from 0⋅6 to
2⋅8 per cent between registries. Details of these ‘missing
patients’ are shown in Tables 2 and 3.
Accuracy of the data
Most discrepancies were observed in postoperative compli-
cations and ASA score (Tables 2 and 3). In 3⋅0–7⋅5 per cent
of the total number of patients in the sample, registration of
postoperative complications was discrepant, either wrongly
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registered or not registered. In 8⋅5–11⋅4 per cent of the
total number of patients, an incorrect ASA score was reg-
istered or missing.
Results of the procedures
In 29 of 174 data verification processes performed, the
quality of data was assessed as ‘insufficient’ according to
the criteria. The number of hospitals that responded to
the results or lodged an objection ranged from 6 to 22 per
registry (Tables 2 and 3).
Lessons learned from the results of each
verification
An overview of the derived lessons is shown in Table 4.
As concluded from discussions with the registrars, the
most common discrepancies in the verifications seemed
to be caused by unclear definitions and descriptions of
variables. This was seen in six of seven verifications. The
variables with the most discrepancies included the M sta-
tus of the tumour, ASA score, the urgency of surgery,
intraoperative complications, postoperative complications,
reinterventions, and the number of days in the ICU. Incor-
rect inclusion and incorrect exclusion of patients in the
registries were also observed.
Discussion
This study showed that verification of the completeness
and accuracy of the registry is essential. The strength of the
described process is that a dedicated team within the audit
organization initiates and coordinates nationwide data ver-
ifications of the registries. By learning from every verifica-
tion, the process of verification was improved continuously.
Data verificationmay help to improve the survey of the reg-
istries and thereby contribute to higher quality data sets.
The most important lesson derived from the verification is
the need for clear definitions of variables.
In the first verification procedures, many of the miss-
ing patients had severe complications or had died. These
discrepancies may have happened because hospitals were
afraid to be criticized if they registered all patients with
complications. Another explanationmight be that hospitals
were not capable of following some of their patients with
complications, as these patients are often treated on differ-
ent wards (such as the ICU) or even transferred to another
hospital. Because the registry is used to compare hospitals,
it is imperative that all hospitals have a complete registry.
Verification of data completeness may stimulate hospitals
to adhere to the proposed rules of data entry.
The verification of data accuracy is also important. One
of the requirements for accurate data is the use of clear
definitions for multi-interpretable variables.Many discrep-
ancies, however, were seen for simple, uni-interpretable
variables, such as date of surgery and date of discharge.
Because length of stay and waiting times are frequently
used as quality indicators, these results indicate that simple
variables should also be verified.
By detecting common discrepancies, such as those result-
ing from unclear description of items, the survey could
be improved by the clarification of definitions, to prevent
incorrect data in the future. Furthermore, by reporting
erroneous data, registrars in hospitals can learn lessons and
improve the registrations. A side-effect of integrated data
verification in the cycle of clinical auditing might be that it
stimulates hospitals to register correctly, because they know
their data will be verified. This so-called Hawthorne effect
describes improved results that might result from increased
awareness for an outcome, in this situation the collection of
correct data14.
All of these mechanisms could benefit the quality of
the data sets and may lead to more valid registries and
more reliable data for outcome research. Valid registries
are important because the results of quality indicators
are publicly available for policy-makers, health insurance
companies and patient federations.
The described process also has limitations, which could
be improved upon. Hospitals that might intentionally reg-
ister incorrectly or incompletely were not identified by
the present procedure because signing up for data verifica-
tion was voluntary. Hospitals can influence their published
results by intentionally registering incorrect or incomplete
data. This might be a problem because the results are used
for clinical auditing and comparisons between hospitals.
A counter-argument for making verification mandatory is
that some medical specialists already feel criticized by clin-
ical auditing as it takes some time. Forcing them to have
data verification may create resistance in the field. For
the integrity of verification, however, it is desirable that
the National Health Care Institute (Zorginstituut Neder-
land) declares the process of data verification mandatory.
Another possibility could be that details on sign-up and
participation in data verification become publicly transpar-
ent, and could be used to assess the validity of indicator
results for individual hospitals.
Another limitation in the present procedure is the strug-
gle to verify the completeness of the registry. At present,
hospitals are free to choose which patient list they provide.
A frequently used patient list is one extracted from the elec-
tronic patient record system. This strategy is not protected
against flaws, because this list could be the same as that used
to select patients for registration. A further disadvantage of
this system is that hospitals couldmanipulate the patient list
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if they wanted to ‘hide’ patients with severe complications.
The results of the verifications, however, showed that use
of these self-provided lists succeeded in identifying unreg-
istered patients.
To improve registries further and provide valuable, ver-
ified, benchmark data to all parties involved, DICA aims
to develop a system in which data verification becomes a
continuous process, as part of the registry. For this pur-
pose, data verification is included in the annual budget.
This year will be the first in which data verification will
be repeated in two registries that have been verified previ-
ously, 3 years ago.
Regarding the optimal sample size for verification, dif-
ficulties in finding a balance between the cost aspect and
certainty of the verification were experienced in the past. In
the near future, a pilot will be started to verify clinical out-
come registry data in a more automated process. This pilot
aims to select patients with high risk of discrepancy15. The
hypothesis is that verification of these high-risk patients
will lead to a higher sensitivity for discrepancies when the
same sample size is used as in the present procedure. As
sample size directly influences costs, this procedure will be
more cost-effective. This pilot is to be funded by Stichting
Kwaliteitsgelden Medisch Specialisten (SKMS), a Dutch
foundation with a policy of improving quality for medical
specialists, and which is part of the Dutch Federation of
Medical Specialists.
For most verifications, the absence of clear and uniform
definitions of items led to the most discrepancies. DICA
will make an important improvement by creating uniform,
clear and correct definitions for items in all registries.
Recently, a project was launched for this purpose. In this
project, as many items as possible will be defined equally
in all registries, with an attempt to use existing guidelines,
classifications and definitions, such as the definitions used
in SNOMED Clinical Terms and ICD-10 codes. SKMS
also supports this project.
It is expected that registration of data will become
increasingly automated in the near future. The authors
envisage that correct data from electronic patient records
will be uploaded automatically to the registry without the
use of data managers.
Collaborators
R. Veenstra (Medical Research Data Management, Deven-
ter, the Netherlands) is a collaborating author.
Acknowledgements
The authors thank all medical specialists, registrars,
physician assistants and administrative nurses for data
registration in the DICA databases, as well as the data
verification committee for their input during development
of the data verification procedures.
Disclosure: The authors declare no conflict of interest.
References
1 Ferguson TB Jr, Peterson ED, Coombs LP, Eiken MC,
Carey ML, Grover FL et al.; Society of Thoracic Surgeons
and the National Cardiac Database. Use of continuous
quality improvement to increase use of process measures in
patients undergoing coronary artery bypass graft surgery: a
randomized controlled trial. JAMA 2003; 290: 49–56.
2 Patel NK, Sarraf KM, Joseph S, Lee C, Middleton FR.
Implementing the National Hip Fracture Database: an audit
of care. Injury 2013; 44: 1934–1939.
3 van Leersum NJ, Snijders HS, Wouters MW, Henneman D,
Marijnen CA, Rutten HR et al.; Dutch Surgical Colorectal
Cancer Audit Group. Evaluating national practice of
preoperative radiotherapy for rectal cancer based on clinical
auditing. Eur J Surg Oncol 2013; 39: 1000–1006.
4 Busweiler LA, Wijnhoven BP, van Berge Henegouwen MI,
Henneman D, van Grieken NC, Wouters MW et al.; Dutch
Upper Gastrointestinal Cancer Audit (DUCA) Group. Early
outcomes from the Dutch Upper Gastrointestinal Cancer
Audit. Br J Surg 2016; 103: 1855–1863.
5 Van Leersum NJ, Snijders HS, Henneman D, Kolfschoten
NE, Gooiker GA, ten Berge MG et al. The Dutch surgical
colorectal audit. Eur J Surg Oncol 2013; 39: 1063–1070.
6 Dutch Institute for Clinical Auditing.Make Care Count. www
.DICA.nl [accessed 30 January 2019].
7 van Bommel AC, Spronk PE, Vrancken Peeters MT, Jager A,
Lobbes M, Maduro JH et al.; NABON Breast Cancer Audit.
Clinical auditing as an instrument for quality improvement
in breast cancer care in the Netherlands: the national
NABON Breast Cancer Audit. J Surg Oncol 2017; 115:
243–249.
8 Dutch Institute for Clinical Auditing. Annual Report 2016.
https://dicanl/jaarrapportage-2016 [accessed 30 January
2019].
9 Zorginstituut Nederland. Zorginzicht. https://www
.zorginzicht.nl/Paginas/Home.aspx [accessed 30 January
2019].
10 Cundall-Curry DJ, Lawrence JE, Fountain DM, Gooding
CR. Data errors in the National Hip Fracture Database:
a local validation study. Bone Joint J 2016; 98-B: 1406–1409.
11 Linder G, Lindblad M, Djerf P, Elbe P, Johansson J,
Lundell L et al. Validation of data quality in the Swedish
National Register for Oesophageal and Gastric Cancer. Br
J Surg 2016; 103: 1326–1335.
12 Medical Research and Data Management. About Us. https://
www.mrdm.nl/page/about-mrdm [accessed 30 January
2019].
13 Pathologisch Anatomisch Landelijk Geautomatiseerd
Archief (PALGA) Foundation. The Nationwide Network and
© 2019 The Authors. www.bjsopen.com BJS Open 2019; 3: 857–864
BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd
864 L. R. van der Werf, S. C. Voeten, C. M. M. van Loe, E. G. Karthaus, M. W. J. M. Wouters and H. A. Prins
Registry of Histo- and Cytopathology in the Netherlands (PALGA
Foundation). http://www.palga.nl/en/about-stichting-palga/
stichting-palga.html [accessed 30 January 2019].
14 Roethlisberger FJ, Dickson WJ.Management and the Worker.
Harvard University Press: Cambridge, 1939.
15 Siregar S, Groenwold RH, Versteegh MI, Noyez L, ter Burg
WJ, Bots ML et al. Gaming in risk-adjusted mortality rates:
effect of misclassification of risk factors in the benchmarking
of cardiac surgery risk-adjusted mortality rates. J Thorac
Cardiovasc Surg 2013; 145: 781–789.
© 2019 The Authors. www.bjsopen.com BJS Open 2019; 3: 857–864
BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd
